I
iTeos Therapeutics D
D
ITOS
10.120
USD
0.01
(0.10%)
مفتوح الان
حجم التداول
1,693
الربح لكل سهم
-3
العائد الربحي
-
P/E
-3
حجم السوق
387,330,805
العنوان: iTeos Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.